What is the Prognosis for Patients with T790M Mutation?
The prognosis for patients with the T790M mutation has improved with the advent of third-generation TKIs. While the presence of T790M indicates a more complex disease state, targeted therapies like osimertinib have been successful in managing this mutation, offering patients a better quality of life and extended survival rates compared to older treatments.
